Ibrahim Elhoussieny
About Ibrahim Elhoussieny
Ibrahim Elhoussieny is the Vice President of Medical Affairs at Kite Pharma, specializing in oncology and cell therapy. He has over 22 years of experience in medical affairs, having held various leadership roles at Novartis and GSK, and has a strong educational background in medicine and business administration.
Current Role at Kite Pharma
Ibrahim Elhoussieny serves as the Vice President and Global Head of Oncology and Cell Therapy Medical Affairs at Kite Pharma. He has held this position since 2018, contributing to the company's focus on innovative cancer therapies. His leadership in medical affairs encompasses strategic oversight and the integration of clinical insights into the development of oncology and cell therapy products.
Previous Experience at Novartis
Before his current role, Ibrahim Elhoussieny worked at Novartis in various capacities. He served as the Head of Oncology Medical Affairs for East Europe, the Middle East, and Africa from 2008 to 2010. He also held the position of Country Medical Director for Oncology in the UK and Ireland from 2010 to 2013. His tenure at Novartis included roles such as Vice President Sr Franchise Head for Oncology Global Medical Affairs from 2013 to 2018 and Head of Medical Affairs Excellence for Emerging Growth Markets from 2006 to 2008.
Early Career at GSK and Novartis
Ibrahim Elhoussieny began his career in the pharmaceutical industry as a Clinical Research Associate at GSK in Egypt from 1997 to 1998. He then joined Novartis, where he held various positions, including Medical Advisor and Medical Manager for General Medicines from 2004 to 2006, and Clinical Research Section Head from 2001 to 2004. His early roles laid the foundation for his extensive experience in medical affairs.
Educational Background
Ibrahim Elhoussieny holds a medical degree (M.B.B.ch) from Ain Shams University, where he studied from 1987 to 1993. He further pursued a Master of Science in Radiology from the same institution between 1998 and 2001. Additionally, he earned an MBA in Business Administration and Management from Maastricht School of Management from 2003 to 2005. He also obtained the Educational Commission for Foreign Medical Graduates (ECFMG) Certificate.
Professional Expertise
With over 22 years of leadership experience in medical affairs and development, Ibrahim Elhoussieny has specialized in oncology and cell therapy. He practiced medicine for eight years prior to transitioning into the pharmaceutical sector, where he has developed a comprehensive understanding of both clinical and business aspects of healthcare.